Vol 25, No 4 (2020)
Published online: 2020-07-01

open access

Page views 266
Article views/downloads 298
Get Citation

Connect on Social Media

Connect on Social Media

Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management)

Marc J. Rogers1, Marigdalia K. Ramirez-Fort234, James A. Kashanian3, Seth A. Broster1, Jaime Matta5, Sean S. Mahase6, Digna V. Fort2, M. Junaid Niaz3, Shearwood McClelland7, Neil H. Bander3, Migdalia Fort2, Christopher S. Lange24, Peter Schlegel3, John P. Mulhall8
DOI: 10.1016/j.rpor.2020.03.011
Rep Pract Oncol Radiother 2020;25(4):619-624.


Prostate cancer is the most common malignancy in men and the second leading cause of cancer-related death in men. Radiotherapy is a curative option that is administered via external beam radiation, brachytherapy, or in combination. Sexual dysfunction is a common toxicity following radiotherapy, similar to men undergoing radical prostatectomy, but the etiology is different. The pathophysiology of radiation-induced sexual dysfunction is multi-factorial, and the toxicity is a major cause of impaired quality of life among long-term prostate cancer survivors. Management of a patient’s sexual function during and after radiotherapy requires multidisciplinary coordination of care between radiation oncology, urology, psychiatry, pharmacy, and dermatology. This review provides a framework for clinicians to better understand prostatic radiotherapy-induced sexual dysfunction diagnosis, evaluation, and a patient-centered approach to toxicity preventive strategies and management.

Article available in PDF format

View PDF Download PDF file

Reports of Practical Oncology and Radiotherapy